Breakthrough Vaccine Offers Hope for Pancreatic Cancer Treatment
A team at Memorial Sloan Kettering has made significant progress in developing an mRNA vaccine for pancreatic cancer, a disease notoriously difficult to treat. About 90% of patients diagnosed with pancreatic cancer do not survive. In a small trial three years ago, the team tested the vaccine’s safety on 16 patients. The results were promising: … Read more